Alfred E. Mann to Give Keynote Address at Medtech Insight's 'Investment In Innovation: A Preview of Early-Stage Medical Technology Companies' Conference.Business Editors/Health/Medical Writers Medtech Insight 2004 Investment in Innovation NEWPORT BEACH Newport Beach, residential and resort city (1990 pop. 66,643), Orange co., S Calif., on Newport Bay and the Pacific Ocean; inc. 1906. It is a popular seaside resort and yachting center. Manufactures include electrical and medical equipment, computers, boats, and adhesives. , Calif.--(BUSINESS WIRE)--Jan. 7, 2004 Medtech Insight, LLC (Logical Link Control) See "LANs" under data link protocol. LLC - Logical Link Control (www.medtechinsight.com), a leading provider of technology and market information to the medical device and investment communities, has announced that Alfred E. Mann Alfred E. Mann (born 1925, Portland, OR), who is also known as Al Mann, is an American entrepreneur and philanthropist. He is a billionaire. Born and raised in Portland, his father was English and mother Polish. , distinguished medical technology industry leader, innovator and entrepreneur, and Chairman of Advanced Bionics, among many other medical technology companies, will give the keynote address at Medtech Insight's 10th Investment In Innovation (In3): A Preview of Early-Stage Medical Technology Companies conference, being held February 24-25, 2004, at the Hyatt Regency Irvine in Irvine, CA. Mr. Mann's address will be entitled "A Medical Device -- From Idea to Reality." Medtech Insight's In3 conferences are considered the premier forum for senior executives in the medical technology and investment community to preview emerging medical technology companies in need of funding, acquisition and/or strategic partnership. Among his many accomplishments, Mr. Mann is Chairman of Advanced Bionics Corporation, MannKind Corporation, Second Sight, LLC, AlleCure Corporation, and Quallion, LLC, as well as Chairman Emeritus of Pacesetter System, Inc., and MiniMed Inc., all companies founded by Mr. Mann. He is also founder of Medical Research Group, Inc., and Chairman of CTL See control key. 1. CTL - Checkout Test language. 2. CTL - Compiler Target Language. 3. CTL - Computational Tree Logic Immunotherapy Inc. and Pharmaceutical Discovery Corporation. "We are extremely honored to have Mr. Mann kick off our tenth In3 conference, and our third in Irvine," said Sharon O'Reilly, president and chief executive officer of Medtech Insight. "Mr. Mann's professional accomplishments and honors are extensive, and with his consummate medical technology industry experience he will be a great inspiration to the more than 50 early-stage companies that will be included on the In3 Irvine program, and all other participants." Mr. Mann is currently Chairman of the Board of Trustees board of trustees Politics The posse of thugs who oversee an institution's administration. See Board of directors. of the Alfred Mann Foundation and of the Alfred Mann Institute at the University of Southern California The U.S. News & World Report ranked USC 27th among all universities in the United States in its 2008 ranking of "America's Best Colleges", also designating it as one of the "most selective universities" for admitting 8,634 of the almost 34,000 who applied for freshman admission (USC An abbreviation for U.S. Code. ), medical research foundations founded and endowed principally by Mr. Mann. Since 1998, he has served as a Trustee for USC and as a member of the Board of Overseers of the Keck USC School of Medicine. He has also received many honors, including honorary doctorate degrees from USC, The Johns Hopkins University Johns Hopkins University, mainly at Baltimore, Md. Johns Hopkins in 1867 had a group of his associates incorporated as the trustees of a university and a hospital, endowing each with $3.5 million. Daniel C. and Western University, the "Business Person of the Year" Award from the Los Angeles Business Journal in 2003, and the "Ernest Borgnine Spirit Award" from the American Veterans Association in 2003, to name only a few. Among the presenting companies confirmed thus far for In3 Irvine (more being added; see http://www.medtechinsight.com/in3-10.html for an updated listing) include: ALung Technologies, Andromed, Aquamer, CardioVasc, CeraPedics, Confirma, Cyclotec Advanced Medical Technologies, Densys, Duke Empirical, Eunoe, Harbinger Medical, Impres Medical, ineedmd, Intelligent Medical Devices, Intercept Biomedical Technology, iSense, Microsense, MINRAD, Noviace, OmniCorder Technologies, Pindi Products, Rhythm Technologies, RITA RITA Cardiology A clinical trial–Randomized Intervention Treatment of Angina–comparing the outcome of PCTA vs CABG in Pts with angina. See Angina, Angioplasty, CABG, Percutaneous transluminal angioplasty. Medical Systems, Spineology, TechniScan, Vitalog, VMBC VMBC Van Mildert Boat Club (The Vasclip Company), and Xillix Technologies. A regularly updated listing of the presenting companies, the conference program and other details can be viewed at http://www.medtechinsight.com/in3-10.html. Co-sponsors of the Irvine event include: AdvaMed, Battelle, Business Wire, Dorsey & Whitney LLP LLP - Lower Layer Protocol , Medmarc and The Hartford, PPD (1) (Parallel Presence Detect) The method used by earlier SIMM memory modules to communicate their capacity to the computer. A binary number coming from a parallel set of pins was read by the system, with each pin representing one bit. Contrast with SPD. , Inc., Reimbursement Principles, Ronald Trahan Associates Inc., The MedTech Group, Underwriters Laboratories, and Windhover wind·hov·er n. Chiefly British A kestrel. Information. Since the inception of the "Investment In Innovation (In3)" meeting series, nearly 350 early-stage emerging medical technology companies have presented (see http://www.medtechinsight.com/pastpresenters.html) and nearly 2,700 medical technology executives and investors (see http://www.medtechinsight.com/pastattendees.html) have attended, making it the premier forum for partnering and business development in the medical technology industry. Medtech Insight publishes the "medtech insight" newsletter, a monthly publication covering the latest trends and innovations in the medical technology industry. The company publishes analyses of medtech markets through its Reports group, offers custom consulting and market research, and holds "Investment In Innovation" conferences several times a year. To register for the Irvine conference or for more information on Medtech Insight, please call 949-219-0150 or 888-290-2225 toll-free in the U.S., fax (949) 219-0067, e-mail in3@medtechinsight.com, or visit http://www.medtechinsight.com/in3-10.html. Visit the company's website at www.medtechinsight.com to read more about In3 conferences, including testimonials and success stories from past events, view tables of contents for published and upcoming reports, and download a sample issue of the "medtech insight" newsletter. Website: http://www.medtechinsight.com |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion